Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies

Lymphoid malignancies are complex diseases with distinct biological behaviors, clinical presentations, and treatment responses. Ongoing research and advancements in biotechnology enhance the understanding and management of these malignancies, moving towards more personalized approaches for diagnosis...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 25; no. 17; p. 9253
Main Authors Adamo, Francesco Maria, De Falco, Filomena, Dorillo, Erica, Sorcini, Daniele, Stella, Arianna, Esposito, Angela, Arcaleni, Roberta, Rosati, Emanuela, Sportoletti, Paolo
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.09.2024
Subjects
Aluminum
Animals
Antibodies
Biocompatibility
Cancer therapies
Carbon
Disease
Drug Delivery Systems - methods
Hematologic Neoplasms - diagnosis
Hematologic Neoplasms - therapy
Humans
Leukemia
Lipids
lymphoid malignancies
Lymphoma - diagnosis
Lymphoma - therapy
Medical research
Nanomedicine - methods
Nanoparticles
Nanoparticles - chemistry
Nanoparticles - therapeutic use
Nanotechnology - methods
Polyethylene glycol
precision medicine
Precision Medicine - methods
Quantum dots
Toxicity
Tumors
precision medicine
lymphoid malignancies
nanoparticles
Online AccessGet full text

Cover

More Information
Summary:Lymphoid malignancies are complex diseases with distinct biological behaviors, clinical presentations, and treatment responses. Ongoing research and advancements in biotechnology enhance the understanding and management of these malignancies, moving towards more personalized approaches for diagnosis and treatment. Nanotechnology has emerged as a promising tool to improve some limitations of conventional diagnostics as well as treatment strategies for lymphoid malignancies. Nanoparticles (NPs) offer unique advantages such as enhanced multimodal detection, drug delivery, and targeted therapy capabilities, with the potential to improve precision medicine and patient outcomes. Here, we comprehensively examine the current landscape of nanoconstructs applied in the management of lymphoid disease. Through a comprehensive analysis of preclinical studies, we highlight the translational potential of NPs in revolutionizing the field of hematological malignancies, with a specific focus on lymphoid neoplasms.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1661-6596
1422-0067
1422-0067
DOI:10.3390/ijms25179253